Ulcerative colitis trials in Chile
7 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Osorno, Santiago
- Age
- 18 years and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - Phase 1/2Taking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Santiago
- Age
- 18 years to 75 years
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - Phase 2Taking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Osorno, Santiago
- Age
- 18 years to 75 years
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - Phase 3Taking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Santiago, Viña del Mar
- Age
- 16 years to 80 years
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - No phaseTaking peopleMediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission
- Where
- Santiago
- Age
- 18 years to 60 years
- People
- 45
- Run by
- Pontificia Universidad Catolica de Chile
See details and how to joinNCT07752446 - No phaseTaking peoplePROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
- Where
- Santiago
- Age
- 18 years to 75 years
- People
- 72
- Run by
- Pontificia Universidad Catolica de Chile
See details and how to joinNCT06758024 - No phaseTaking peopleEarly Inflammatory Bowel Disease Progression
- Where
- Santiago
- Age
- 18 years to 100 years
- People
- 140
- Run by
- Pontificia Universidad Catolica de Chile
See details and how to joinNCT06756100